AKESF 주가 차트
AKESF 주가 예측
Akeso, Inc.
$11.13
-8.3%
$-1
종가: Sep 02, 16:00:00 GMT-4
$11.5
3.32%
$0.36
애프터마켓: Sep 02, 19:59:36 GMT-4
뒤로
Akeso, Inc. (AKESF) 주가 예측
주요 통계
이전 종가
$12.13
시가
$11.5
일일 범위
$11.19 - $11.5
52주 범위
$10.5 - $21.35
거래량
300
평균 거래량
1.5K
배당수익률
--
EPS(TTM)
-0.16
시가총액
$10.5B
AKESO INC.란 무엇인가요?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company employs 3,761 full-time employees The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
